Safety of linezolid in patients with baseline thrombocytopenia

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 4, 2008, Pages 850-851

  Grim, Shellee A ^a   Rene, Lisa ^b   Gupta, Sandeep ^c   Clark, Nina M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bleeding; Myelosuppression; Platelets

Indexed keywords

COTRIMOXAZOLE; GANCICLOVIR; HEPARIN; LINEZOLID; LOW MOLECULAR WEIGHT HEPARIN; PIPERACILLIN PLUS TAZOBACTAM; VALGANCICLOVIR;

ADULT; AGED; BACTERIAL INFECTION; BLEEDING; COMORBIDITY; CONTROLLED STUDY; DRUG EXPOSURE; DRUG SAFETY; DRUG WITHDRAWAL; EPISTAXIS; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL PATIENT; HUMAN; LETTER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT DURATION;

ACETAMIDES; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXAZOLIDINONES; THROMBOCYTOPENIA;

EID: 52949131930     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn285     Document Type: Letter

References (8)

1. Zyvox [package insert]. New York, NY: Pfizer, Inc., 2007.
2. Gerson SL, Kaplan SL, Bruss JB et al. Hematologic effects of linezolid: Summary of clinical experience. Antimicrob Agents Chemother 2002; 46: 2723-6.
3. Attassi K, Hershberger E, Alam R et al. Thrombocytopenia associated with linezolid therapy. Clin Infect Dis 2002; 34: 695-8.
4. Orrick JJ, Johns T, Janelle J et al. Thrombocytopenia secondary to linezolid administration: What is the risk? Clin Infect Dis 2002; 35: 348-9.
5. Smith PF, Birmingham MC, Noskin GA et al. Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia. Ann Oncol 2003; 14: 795-801.
6. Nasraway SA, Shorr AF, Kuter DJ et al. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use. Clin Infect Dis 2003; 37: 1609-16.
7. Grau S, Morales-Molina JA, Mateu-de Antonio J et al. Linezolid: low pro-treatment platelet values could increase the risk of thrombocytopenia. J Antimicrob Chemother 2005; 56: 440-1.
8. Wu VC, Wang YT, Wang CY et al. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease. Clin Infect Dis 2006; 42: 66-72.